Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial

Status unconfirmed · Not applicable

Conditions studied: Severe Sepsis, Acute Heart Failure

In brief

The purpose of this study is to evaluate the impact that the Venus 1000 non-invasive CVP system has on the management of emergency department (ED) patients with fluid sensitive conditions.

Key facts

Study ID

NCT02258984

Run by

Mespere Lifesciences Inc.

People needed

80

Starts

2014-10-01

Expected to finish

2015-12-01

Last updated by the study team

2015-09-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years old or greater
• English speaking
• Clinical diagnosis of: 1) Severe Sepsis, or 2) Acute Heart Failure

You may not qualify if…

• Traumatic injuries
• Active bleeding
• Pregnancy
• Prisoners
• Central venous catheter placement in the internal jugular or subclavian veins
• Bilateral external jugular vein catheterizations
• Concurrent enrollment into an interventional clinical trial that may affect subject treatment

Where it is running

• Detroit Receiving Hospital — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.